Clinical trial
Comparison of Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) and Taxol®…
NCT00100139 · INSYS Therapeutics Inc, Industry · Completed
Key facts
| NCT number | NCT00100139 |
|---|---|
| Title | Comparison of Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) and Taxol® Pharmacokinetics in Patients With Advanced Cancer |
| Official title | A Randomized Two-Period Crossover, Clinical Bioequivalence Study Comparing the Pharmacokinetics of Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) Formulation Versus Taxol® in Patients With Advanced Cancer |
| Lead sponsor | INSYS Therapeutics Inc, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Neoplasm |
| Intervention type | Drug |
| Interventions | Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU), Paclitaxel for injection (Taxol) |
| Enrollment | 48 |
| Start date | Nov 1, 2004 |
| Primary completion | Nov 1, 2006 |
| Completion | Jun 1, 2010 |
| First posted | Dec 24, 2004 |
| Last update posted | Jul 4, 2011 |
| Countries | Germany, Netherlands, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: